Serine 165 phosphorylation of SHARPIN regulates the activation of NF-κB.

Cell Biology Immunology Molecular Biology

Journal

iScience
ISSN: 2589-0042
Titre abrégé: iScience
Pays: United States
ID NLM: 101724038

Informations de publication

Date de publication:
22 Jan 2021
Historique:
received: 20 07 2020
revised: 27 10 2020
accepted: 09 12 2020
entrez: 4 1 2021
pubmed: 5 1 2021
medline: 5 1 2021
Statut: epublish

Résumé

The adaptor SHARPIN composes, together with the E3 ligases HOIP and HOIL1, the linear ubiquitin chain assembly complex (LUBAC). This enzymatic complex catalyzes and stamps atypical linear ubiquitin chains onto substrates to modify their fate and has been linked to the regulation of the NF-κB pathway downstream of most immunoreceptors, inflammation, and cell death. However, how this signaling complex is regulated is not fully understood. Here, we report that a portion of SHARPIN is constitutively phosphorylated on the serine at position 165 in lymphoblastoid cells and can be further induced following T cell receptor stimulation. Analysis of a phosphorylation-resistant mutant of SHARPIN revealed that this mark controls the linear ubiquitination of the NF-κB regulator NEMO and allows the optimal activation of NF-κB in response to TNFα. These results identify an additional layer of regulation of the LUBAC and unveil potential strategies to modulate its action.

Identifiants

pubmed: 33392484
doi: 10.1016/j.isci.2020.101939
pii: S2589-0042(20)31136-6
pmc: PMC7773595
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101939

Informations de copyright

© 2020 The Author(s).

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Nat Immunol. 2003 Jun;4(6):579-85
pubmed: 12730692
Nat Commun. 2015 Nov 03;6:8777
pubmed: 26525107
Front Oncol. 2018 Nov 09;8:498
pubmed: 30474008
Mol Cell. 2011 Feb 4;41(3):354-65
pubmed: 21292167
Cell. 2013 Jun 6;153(6):1312-26
pubmed: 23746843
Annu Rev Immunol. 2012;30:565-610
pubmed: 22224767
Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):3909-13
pubmed: 9108078
Nature. 2018 May;557(7703):112-117
pubmed: 29695863
Nature. 2011 Mar 31;471(7340):591-6
pubmed: 21455173
Genes Immun. 2007 Jul;8(5):416-21
pubmed: 17538631
PLoS One. 2015 Nov 23;10(11):e0143423
pubmed: 26600301
Nature. 2011 Mar 31;471(7340):633-6
pubmed: 21455180
Cancer Discov. 2014 Apr;4(4):480-93
pubmed: 24491438
Biochim Biophys Acta. 2015 Jun;1854(6):601-8
pubmed: 25315852
Mol Cell. 2019 Mar 21;73(6):1138-1149.e6
pubmed: 30901564
Nat Cell Biol. 2011 Sep 25;13(11):1315-24
pubmed: 21947080
Cold Spring Harb Perspect Biol. 2011 Dec 01;3(12):
pubmed: 22134888
Biochem Biophys Res Commun. 2017 Mar 25;485(1):152-159
pubmed: 28189684
J Exp Med. 2001 Dec 17;194(12):1861-74
pubmed: 11748286
Nat Rev Immunol. 2005 Oct;5(10):749-59
pubmed: 16175180
Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11536-41
pubmed: 21709223
Cell Res. 2008 Nov;18(11):1096-104
pubmed: 18711448
Nat Rev Immunol. 2004 Apr;4(4):301-8
pubmed: 15057788
Immunol Rev. 2015 Jul;266(1):190-207
pubmed: 26085216
Mol Cell. 2014 May 8;54(3):335-48
pubmed: 24726323
J Cell Sci. 2016 May 1;129(9):1775-80
pubmed: 27006117
Nat Immunol. 2016 Mar;17(3):286-96
pubmed: 26829767
Mol Cell Biol. 2016 Nov 28;36(24):3010-3018
pubmed: 27669734
Cell Rep. 2013 Nov 14;5(3):619-28
pubmed: 24210817
Nat Cell Biol. 2020 Jun;22(6):663-673
pubmed: 32393887
Blood. 2014 Apr 3;123(14):2199-203
pubmed: 24497531
Nature. 2009 Jun 4;459(7247):717-21
pubmed: 19412164
Mol Cell. 2016 Sep 15;63(6):990-1005
pubmed: 27591049
Elife. 2014 Dec 02;3:
pubmed: 25443632
Nat Commun. 2016 Nov 18;7:13353
pubmed: 27857075
EMBO J. 2006 Oct 18;25(20):4877-87
pubmed: 17006537
Mol Syst Biol. 2015 Jun 02;11(6):810
pubmed: 26038114
Cell. 2012 Jan 20;148(1-2):213-27
pubmed: 22265413
FEBS J. 2016 Feb;283(3):403-12
pubmed: 26573773
Mol Cell. 2012 Jun 29;46(6):746-58
pubmed: 22607974
Nat Cell Biol. 2009 Feb;11(2):123-32
pubmed: 19136968
Nature. 2011 Mar 31;471(7340):637-41
pubmed: 21455181
J Cell Sci. 2019 Jan 18;132(2):
pubmed: 30659056
Cell Rep. 2014 Oct 9;9(1):153-165
pubmed: 25284787
Science. 2002 Jun 7;296(5574):1873-6
pubmed: 12052961
Immunity. 2017 Jul 18;47(1):51-65.e7
pubmed: 28666573
Nature. 2018 Jul;559(7712):120-124
pubmed: 29950720
PLoS One. 2010 Jun 30;5(6):e11380
pubmed: 20614026

Auteurs

An Thys (A)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.

Kilian Trillet (K)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.

Sara Rosińska (S)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.

Audrey Gayraud (A)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.

Tiphaine Douanne (T)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.

Yannic Danger (Y)

Etablissement Français du Sang (EFS), PFBI, Rennes, France.

Clotilde C N Renaud (CCN)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.

Luc Antigny (L)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.

Régis Lavigne (R)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
Protim, Univ Rennes, Rennes, France.

Charles Pineau (C)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
Protim, Univ Rennes, Rennes, France.

Emmanuelle Com (E)

Université de Rennes, Inserm, EHESP, Irset (Institut de recherche en santé, environnement et travail) - UMR_S 1085, Rennes, France.
Protim, Univ Rennes, Rennes, France.

Franck Vérité (F)

Etablissement Français du Sang (EFS), PFBI, Rennes, France.

Julie Gavard (J)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.
Integrated Center for Oncology, ICO, St. Herblain, France.

Nicolas Bidère (N)

CRCINA, Inserm, CNRS, Université de Nantes, Université d'Angers, Nantes, France.

Classifications MeSH